YOLFTbeta
60

Hunan Fangsheng Pharm Co Ltd

603998 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

9.69CNY-0.24 (-2.42%)

Price History

Full chart

Market Stats

Previous Close9.93
Open9.93
Day Range9.66 – 9.96
52-Week Range8.64 – 13.50
Volume8.09M
Market Cap4.55B
P/E (TTM)13.63
Forward P/E0.00
EPS0.76
Dividend Yield4.83%
Beta0.28
50-Day Avg10.16
200-Day Avg10.77

About

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets; Lysine Vitamin B12 granules; Cephalosporin tablets, Jinying capsules; Pudilan anti-inflammatory tablets; Tenghuang Jian Gu tablets; Xiaoer Jingxing Zhike granules; Yizhemaibu tablets; Xuanqi Jian tablets; Xuanqi Jian Gu tablets, Qiangli Pipa Gao, strong loquat syrup, and others. Hunan Fangsheng Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Xiaoli Zhou
  • Employees1.87K
  • HeadquartersNo. 299, Jiayun Road, Changsha, China, 410205, China
  • Websitehttps://www.fangsheng.com.cn

Leadership

  • Ms. Xiaoli ZhouGM & Chairman · b. 1973
  • Ms. Xiangqi CaoFinancial Director & Accounting Supervisor · b. 1974
  • Mr. Chen BoDeputy GM & Director · b. 1979
  • Mr. Shi HeBoard Secretary · b. 1985

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue262.68M332.31M400.26M415.61M468.56M534.26M720.77M1.05B1.09B1.28B1.57B1.79B1.63B1.78B1.75B
Growth (%)-+26.51%+20.45%+3.84%+12.74%+14.02%+34.91%+45.83%+4.06%+16.92%+22.54%+14.36%-9.12%+9.15%-1.75%
Cost of Revenue153.27M183.67M236.43M219.32M206.78M271.60M289.73M274.98M301.16M468.18M566.27M589.28M522.25M517.01M489.54M
Gross Profit109.40M148.64M163.84M196.29M261.78M262.66M431.03M776.10M792.59M810.58M1.00B1.20B1.11B1.26B1.26B
Gross Margin41.65%44.73%40.93%47.23%55.87%49.16%59.80%73.84%72.47%63.39%63.86%67.12%67.93%70.91%71.97%
Operating Expense50.03M72.88M78.86M101.29M152.89M178.47M350.83M684.01M696.23M738.21M901.01M870.68M909.85M975.14M931.20M
Operating Income59.37M75.75M84.98M95.00M108.89M84.18M80.21M92.08M96.36M72.37M99.69M332.04M196.45M285.34M325.70M
Operating Margin22.60%22.80%21.23%22.86%23.24%15.76%11.13%8.76%8.81%5.66%6.36%18.53%12.06%16.05%18.65%
EBITDA73.08M89.84M102.51M118.01M139.91M116.42M122.28M141.91M159.48M156.72M177.02M419.20M295.88M381.19M448.63M
EBITDA Margin27.82%27.04%25.61%28.39%29.86%21.79%16.97%13.50%14.58%12.26%11.30%23.39%18.17%21.45%25.69%
Net Income51.88M66.11M73.44M80.99M90.68M69.76M59.68M72.99M78.91M63.79M70.04M285.85M186.82M255.22M306.39M
Net Income Margin19.75%19.90%18.35%19.49%19.35%13.06%8.28%6.94%7.21%4.99%4.47%15.95%11.47%14.36%17.54%
R&D9.71M11.73M16.36M19.85M26.34M26.07M29.37M42.35M41.23M53.62M51.40M70.40M107.93M139.21M154.47M
R&D as % of Total Revenue3.70%3.53%4.09%4.78%5.62%4.88%4.07%4.03%3.77%4.19%3.28%3.93%6.63%7.83%8.84%
Interest Expense140.78K27.78K66.23K1.83M5.39M452.66K4.69M5.63M11.22M17.29M18.85M22.95M20.81M22.12M14.80M
Interest Expense % of Total Revenue0.05%0.01%0.02%0.44%1.15%0.08%0.65%0.54%1.03%1.35%1.20%1.28%1.28%1.24%0.85%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets327.38M375.81M466.34M928.43M1.07B1.27B1.37B1.64B1.99B2.24B2.70B2.92B3.08B3.27B3.06B
Total Liabilities68.89M56.98M79.50M86.48M134.94M291.31M335.39M529.81M792.51M977.05M1.40B1.41B1.49B1.53B1.25B
Total Equity235.13M293.75M357.17M807.84M885.44M928.44M984.65M1.05B1.13B1.15B1.20B1.39B1.46B1.62B1.71B
Cash80.22M49.72M126.65M497.21M532.59M363.43M140.66M318.20M156.12M318.85M258.88M399.72M208.98M308.46M276.25M
Total Debt----20.00M65.20M66.29M180.00M305.98M439.00M532.64M529.55M483.20M697.03M-
Net Debt-80.22M-49.72M-126.65M-497.21M-512.59M-298.23M-74.37M-138.20M149.85M120.15M273.76M129.83M274.22M388.57M67.38M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow65.16M24.21M122.97M94.16M90.57M118.70M16.00M176.06M162.58M236.66M185.63M301.63M87.54M194.95M384.63M
Investing Cash Flow-33.91M-45.32M-38.43M-93.62M-59.07M-368.72M-213.87M-58.83M-347.62M-174.15M-230.03M-301.49M-197.40M41.04M-
Financing Cash Flow-7.83M-9.38M-7.60M370.02M-16.12M98.42M-23.89M60.53M19.55M101.23M-14.13M126.58M-91.55M-122.00M-
Capital Expenditure50.65M47.78M54.62M97.37M70.73M167.28M132.84M74.90M199.45M167.76M184.71M171.25M218.78M94.79M102.52M
Free Cash Flow14.51M-23.57M68.35M-3.21M19.84M-48.58M-116.83M101.16M-36.87M68.90M915.70K130.38M-131.24M100.16M282.12M
Dividends Paid6.64M7.50M7.60M-13.08M28.68M8.86M9.62M12.93M51.40M25.77M103.95M174.41M129.50M193.27M
FCF to OCF22.27%-97.38%55.58%-3.41%21.91%-40.93%-730.08%57.46%-22.68%29.11%0.49%43.23%-149.92%51.38%73.35%
Dividend Paid to FCF45.72%-31.81%11.12%-65.94%-59.04%-7.58%9.51%-35.07%74.60%2813.77%79.73%-132.90%129.30%68.51%

Earnings

Report DateApr 28, 2015Jun 30, 2015Oct 28, 2015Mar 29, 2016Apr 19, 2016Aug 24, 2016Sep 30, 2016Dec 31, 2016Apr 18, 2017Aug 24, 2017Oct 28, 2017Dec 31, 2017Apr 27, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Apr 27, 2019Aug 27, 2019Oct 30, 2019Dec 31, 2019Apr 30, 2020Aug 29, 2020Oct 30, 2020Dec 31, 2020Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 31, 2023Apr 20, 2023
EPS Estimate---------------------------------
EPS Actual0.050.060.060.040.040.050.040.030.040.070.07-0.040.060.050.030.030.060.070.040.010.050.040.050.010.050.040.050.020.080.070.460.060.15
Surprise---------------------------------
TimingAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hours--Pre-marketPre-marketPre-market-After-hours---Pre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-market------Pre-marketPre-market

Key Statistics & Ratios

Market Cap4.55B
Enterprise Value4.61B
Trailing P/E13.63
Forward P/E0.00
Price / Sales2.43
Price / Book2.58
EPS0.76
Book Value4.05
Revenue (TTM)1.87B
Gross Profit (TTM)1.39B
EBITDA426.69M
Profit Margin17.91%
Operating Margin21.34%
Return on Equity18.71%
Return on Assets7.13%
Shares Outstanding439.08M
Shares Float269.67M
Beta0.28
Dividend Yield4.83%
Dividend Rate0.50
Payout Ratio39.47%

Dividends

20231×
0.26May 10, 2023
20222×
0.09Sep 30, 20220.15Jun 2, 2022
20211×
0.06Jun 11, 2021
20202×
0.06Sep 29, 20200.06Jun 17, 2020
20191×
0.03Jun 18, 2019
20181×
0.01Jul 16, 2018
20171×
0.01Jul 19, 2017
20161×
0.20May 5, 2016
20151×
0.04Apr 17, 2015

Stock Splits

  • May 5, 20163:1
  • Apr 17, 201513:10